AJMC October 18, 2024
Kyle Munz

Navdeep Tangri, MD, PhD, FRCP, University of Manitoba, speaks to the value of population health strategies in clinical approaches to care delivery for patients with chronic kidney disease (CKD).

Navdeep Tangri, MD, PhD, FRCP, University of Manitoba, explores the topic of risk stratification in chronic kidney disease (CKD), innovations in this area, and how the interplay of population health strategies and policy reformation can benefit patient care. With the belief that CKD risk stratification can optimize the quality of care that patients receive, Tangri shares insights into his experience, what is working, and what could be improved in these processes.

This subject, among others, was explored at the Institute for Value-Based Medicine event, “Optimizing Kidney Health: Advances in Proactive Care...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Conferences / Podcast, Healthcare System, Population Health Mgmt, Provider, Trends
Top 9 population health platforms
KLAS: More Pop Health Customers Seeking Risk Stratification Capabilities
Henry Ford Health Launches Nonprofit Population Health Subsidiary
Henry Ford spins off population health company: 4 details
What Population Health Means for Manufacturers

Share This Article